What is NDC 50742-636?

50742-636 is the product NDC for Quetiapine Fumarate, Quetiapine fumarate 150 mg/1 tablet, extended release, listed with the FDA by Ingenus Pharmaceuticals, LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.

Ingenus Pharmaceuticals, LLC, NDC labeler code 50742. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Quetiapine Fumarate?

214 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Quetiapine Fumarate NDC 50742-636 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)50742-636Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50742-0636Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
50742-636-10	50742063610	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-636-10)Marketed from Aug 31, 2017
50742-636-30	50742063630	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-636-30)Marketed from Aug 31, 2017
50742-636-60	50742063660	60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-636-60)Marketed from Aug 31, 2017
50742-636-90	50742063690	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-636-90)Marketed from Aug 31, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Quetiapine Fumarate
Generic name (nonproprietary): quetiapine fumarate
Active ingredients: Quetiapine fumarate — 150 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Ingenus Pharmaceuticals, LLCNDC labeler code 50742
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208947
Marketing start: Aug 31, 2017
Listing expires: Dec 31, 2026
Identifiers: Product ID 50742-636_57efb2c4-97c7-4f4b-8e1f-e73ec6d6c176SPL ID 57efb2c4-97c7-4f4b-8e1f-e73ec6d6c176SPL set ID 8923c441-c9aa-4b30-89d7-dbaaa7f66656RxCUI 721791, 721794, 721796, 853201, 895670UNII 2S3PL1B6UJ
Pharmacologic class: Atypical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450742063610 followed by a unit qualifier and the quantity

Package 50742-0636-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 5, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Quetiapine extended-release tablet is an atypical antipsychotic indicated for the treatment of: Schizophrenia ( 1.1 ) Bipolar I disorder, manic, or mixed episodes ( 1.2 ) Bipolar disorder, depressive episodes ( 1.2 ) Major depressive disorder, adjunctive therapy with antidepressants ( 1.3 ) 1.1 Schizophrenia Quetiapine extended-release tablets are indicated for the treatment of schizophrenia. The efficacy of quetiapine extended-release tablets in schizophrenia was established in one 6-week and one maintenance trial in adults with schizophrenia. Efficacy was supported by three 6-week trials in adults with schizophrenia and one 6-week trial in adolescents with schizophrenia (13-17 years) treat…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 50742-636

What is NDC 50742-636?: 50742-636 is the product NDC for Quetiapine Fumarate, Quetiapine fumarate 150 mg/1 tablet, extended release, listed with the FDA by Ingenus Pharmaceuticals, LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Quetiapine Fumarate.
What is the active ingredient?: Quetiapine fumarate.
Who is the labeler?: Ingenus Pharmaceuticals, LLC, NDC labeler code 50742. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Quetiapine Fumarate?: 214 other product NDCs are listed under this name. See all Quetiapine Fumarate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Quetiapine Fumarate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Quetiapine Fumarate	Quetiapine fumarate 100 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4701	70518-4701-00
Quetiapine Fumarate	Quetiapine fumarate 25 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4705	70518-4705-00
Quetiapine fumaratequetiapine	Quetiapine fumarate 25 mg/1	TabletOral	Coupler LLC	67046-1116	67046-1116-03
Quetiapine fumaratequetiapine	Quetiapine fumarate 200 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-073	87441-0073-01
Quetiapine fumarate	Quetiapine fumarate 25 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-074	87441-0074-01
Quetiapine fumaratequetiapine	Quetiapine fumarate 50 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-071	87441-0071-01
Quetiapine fumaratequetiapine	Quetiapine fumarate 100 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-072	87441-0072-01
Quetiapine fumaratequetiapine	Quetiapine fumarate 300 mg/1	TabletOral	Coupler LLC	67046-0638	67046-0638-03
Quetiapine fumaratequetiapine	Quetiapine fumarate 100 mg/1	TabletOral	Coupler LLC	67046-0636	67046-0636-03
Quetiapine fumaratequetiapine	Quetiapine fumarate 200 mg/1	TabletOral	Coupler LLC	67046-0637	67046-0637-03

All 215 Quetiapine Fumarate NDCs

Other NDCs under ANDA 208947

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208947
Product	Strength	Form · route	Labeler	Product NDC
Quetiapine Fumarate	Quetiapine fumarate 200 mg/1	Tablet, Extended releaseOral	Novast Laboratories, Ltd.	34908-637
Quetiapine Fumarate	Quetiapine fumarate 150 mg/1	Tablet, Extended releaseOral	Novast Laboratories, Ltd.	34908-636
Quetiapine Fumarate	Quetiapine fumarate 300 mg/1	Tablet, Extended releaseOral	Novast Laboratories, Ltd.	34908-638
Quetiapine Fumarate	Quetiapine fumarate 400 mg/1	Tablet, Extended releaseOral	Novast Laboratories, Ltd.	34908-639
Quetiapine Fumarate	Quetiapine fumarate 50 mg/1	Tablet, Extended releaseOral	Ingenus Pharmaceuticals, LLC	50742-635
Quetiapine Fumarate	Quetiapine fumarate 400 mg/1	Tablet, Extended releaseOral	Ingenus Pharmaceuticals, LLC	50742-639
Quetiapine Fumarate	Quetiapine fumarate 200 mg/1	Tablet, Extended releaseOral	Ingenus Pharmaceuticals, LLC	50742-637
Quetiapine Fumarate	Quetiapine fumarate 300 mg/1	Tablet, Extended releaseOral	Ingenus Pharmaceuticals, LLC	50742-638